Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head

PHASE3TerminatedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2017

Study Completion Date

November 30, 2018

Conditions
Osteonecrosis of the Femoral Head
Interventions
DRUG

Core decompression/PREOB® implantation

All patients will undergo a core decompression under general anesthesia combined with the implantation of PREOB® into the necrotic lesion (single administration).

DRUG

Core decompression/placebo implantation

All patients will undergo a core decompression under general anesthesia combined with the implantation of placebo into the necrotic lesion (single administration).

Sponsors
All Listed Sponsors
lead

Bone Therapeutics S.A

INDUSTRY

NCT01529008 - Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head | Biotech Hunter | Biotech Hunter